Results

Total Results: 8,263 records

Showing results for "topical treatment".

361. Development of a Computerized Adverse Drug Event (ADE) Monitor in the Outpatient Setting (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol2/Seger.pdf
     January 01, 2003 - The medication has a low adverse reaction profile, but the therapy is redundant and thus an error. … (2 active ACE inhibitors) Drug Duplicate therapy (2 active Angiotensin receptor blockers) Drug Serum … has had a topical allergic reaction to a medication. … populations, different systems of care (e.g., the presence of an anticoagulation service), different local treatment … The trigger that looked at the use of topical steroids is one example.

362. 2023 National Healthcare Quality and Disparities Report (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2023nhqdr-introduction-rev.pdf
     December 07, 2023 - The extensive literature review included in a third report, Unequal Treatment, 3 drew attention to disparities … Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. … Washington, DC: National Academies Press; 2003. https://www.nap.edu/catalog/12875/unequal-treatment- … https://www.nap.edu/catalog/12875/unequal-treatment-confronting-racial-and-ethnic-disparities-in-health-care … Public Health Emergency Mitigating SARS-CoV-2 Transmission Accelerating Development of COVID-19 Tests, Treatments

363. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0262_05-11-2007.pdf
     January 01, 2007 - What constitutes an adequate diagnostic evaluation on which to base treatment of UI? 2. … How effective is pharmacologic treatment of UI? 3. … How effective is non-pharmacologic treatment of UI? 4. … Does site of care (office, hospital, nursing home) influence choice of best treatment? 5. … Does this make a clinical difference in response to treatment? 8.

364. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0440_06-01-2011.pdf
     January 01, 2011 - Staff-Generated PICO Population(s): Cancer patients completing primary treatment, including adults … cancers, with the potential for improved survival; improvement in quality of life and health due to treatment … of late or continuous treatment side effects or psychosocial effects of having cancer; greater patient … Harms: Earlier initiation of treatment for cancer progression that does not increase survival (thereby … shortening the asymptomatic period with no side effects of treatment); more frequent screening with

365. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/substanceabuse_hi_impact.pdf
     January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … Therefore, an unmet need exists for therapies to address these limitations. … and/or counseling. 13 Opiate substitution therapy is intended to transition the patient to treatment … About buprenorphine therapy. [internet].

366. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0210_12-07-2009.pdf
     January 01, 2009 - injury Intervention(s): Physical, behavioral, speech, occupational, and/or cognitive rehabilitation therapies … What is the comparative effectiveness of treatment for TBI for grades I-IV? 2. … For patients, what are the potential harms of TBI treatment interventions? 3. … Are there particular forms of therapy, including number of treatments, length of treatments, frequency … of treatments, or total duration of treatments that are most effective?

367. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0404_01-14-2011.pdf
     January 01, 2011 - Summary: The nominator is interested in the effectiveness and comparative effectiveness of medical treatments … Compare two newer drug therapies, both FDA approved, for the treatment of PAH (inhaled treprostinil … and ambrisentan) to older treatments b. … Compare combination drug therapies to monotherapy drug treatment Pulmonary Arterial Hypertension … Based on disease etiology and severity of the disease, the timing and optimal combinations of drug therapy

368. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0334_08-04-2010.pdf
     January 01, 2010 - Selection Process & Next Steps  Pharmacogenetic testing for CYP2C19 variants for guiding antiplatelet treatment … Intervention(s): Genetic testing for CYP2C19 variants to guide treatment selection. … Because this is a comparison of testing strategies, there exist several treatment options that may be … Note that a no-testing strategy implies treatment following the current guidelines (i.e., clopidogrel … antiplatelet therapy for the prevention of major adverse cardiovascular outcomes, compared to alternative

369. Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay-future_research.pdf
     September 01, 2012 - o Does the use of the SFLC assay influence the type of treatment (e.g., radiation therapy)? … of treatment or use of adjunctive therapy or stem-cell transplantation) in patients with PCDs? … o Does the use of the SFLC assay influence the type of treatment (e.g., radiation therapy)? … of treatment or use of adjunctive therapy or stem-cell transplantation) in patients with PCDs? … Does the use of the SFLC assay influence the type of treatment (e.g., radiation therapy)?”

370. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0064_11-23-2008.pdf
     January 01, 2008 - Document Completion Date: 6-25-09 1 Results of Topic Selection Process & Next Steps  Treatment … Nomination Summary: The anonymous nominator is interested in the comparative risks and benefits of treatments … Does treatment response vary for African-Americans as compared to those who are not African-Americans … Treatment of Open-Angle Glaucoma Nomination Summary Document http://effectivehealthcare.ahrq.gov/index.cfm … There are no recent guidelines on the treatment of glaucoma in the US.

371. Topic 0318 Psychiatric Hospital Discharge NSD FINAL (2)_SJ_Clean-2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0376-140408.pdf
     November 06, 2013 - calls, short-term case management, bridge visits, psychoeducation, referral to assertive community treatment … observation [including emergency department], intensive case management [ICM)], intensive outpatient treatment … including outpatient commitment, Assertive Community Treatment [ACT]) Transition support services … Key Questions from Nominator:  Patient insight into illness  Treatment … sufficient to address safety and dangerousness concerns  Satisfaction with care  Relapse  Treatment

372. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0007_03-17-2008.pdf
     January 01, 2008 - professional association Nomination Summary: The nominator is interested in the most effective therapy … Population(s): Adults with a diagnosis of depression Intervention(s): Treatment of depression after … failure with SSRI Comparator(s): Other antidepressants, cognitive behavioral therapy, or a combination … Outcome(s): Improved symptoms of depression and quality of life, harms associated with treatments … areas of this nomination, no comparative effectiveness reviews were identified that compared all the therapies

373. Recommendation: Oral Health in Adults: Screening and Preventive Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/oral-health-adults-screening-preventive-interventions
     November 07, 2023 - disease, tooth loss, and morbidity, quality of life, functional status, and harms of screening and treatment … outcomes such as cardiovascular or cognitive outcomes, quality of life, or functional status. 1 , 19 Topical … Five trials (n = 971) in adults reported on the effects of topical fluorides (varnish or gel/solution … (adjusted mean difference, −0.04 [95% CI, −0.10 to 0.03]). 1 , 19 The 3 additional trials of other topical … Topical fluoride for caries prevention. J Am Dent Assoc . 2013;144(11):1279-1291.

374. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0368_11-08-2010.pdf
     January 01, 2010 - , sham, or standard treatment. … from specific physical diseases Interventions: Mindfulness-based stress programs Comparators: No treatment … , sham, or standard treatment Outcomes: Patient-reported outcomes, such as stress and well-being, and … clinical biomarker outcomes, such as cortisol Timing: Duration of therapy, duration of improvements … Setting: Group and individual treatment settings Key Questions from Nominator: None

375. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND__0250_05-20-2010.pdf
     January 01, 2010 - Prevention in Atrial Fibrillation Population(s): Adults with AF Intervention(s): Anticoagulation therapy … What are the accuracy and utility of methods of risk stratification to guide choice of therapy (e.g. … What are the comparative benefits and harms of newer surgical and less invasive therapies, such as AVJ … ablation, cardiac resynchronization therapy, left atrial appendage occlusive devices, and autonomic … In recent years, technological advancements, new marketed drugs, and new therapeutic considerations

376. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … with one or more standard therapies, including corticosteroids, immunomodulators, or tumor necrosis … unmet need for new therapeutic options for patients with IBS. … , alternative therapies are needed. … FDA approves two therapies to treat IBS-D. [internet]. Silver Spring (MD): U.S.

377. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0260_07-16-2010.pdf
     January 01, 2010 - Document Completion Date: 12-13-10 1 Results of Topic Selection Process & Next Steps  Treatments … Pharmacological, psychological, or complementary and alternative interventions Comparator(s): No treatment … , placebo, or comparative effectiveness of treatments Outcome(s): Reduced severity of tinnitus … however, there is no single review that addresses all of the interventions that have been studied in the treatment … Treatments for Tinnitus Nomination Summary Document http://effectivehealthcare.ahrq.gov/index.cfm/

378. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1512.pdf
     November 01, 2016 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … or payers may require a step- therapy approach starting with existing endometriosis treatments before … or payers 3 may require step therapy in which patients try existing endometriosis treatments before … They noted its anticipated higher cost than alternative therapies available as generics may increase

379. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … Pharmacologic therapies can address symptoms of hyperactivity and depression, but effective pharmacologic … Cypress Bioscience acquires novel intranasal carbetocin therapy for autism; therapy may represent … Autism treatments and drugs. [internet].

380. Disposition of Comments CER 194 Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-194-disposition-comments-inhaled-corticosteroids.pdf
     March 19, 2018 - If all patients adhered 100% to therapy, intermittent therapy and the need to add more and more controllers … This review is focused on the class comparison of these therapies. … include patients 6 years old and above BI appreciates AHRQ’s thorough review of currently available therapeutic … The results “no difference” means that statistically, there was no difference in the two therapies … We avoid using terms such as “similar” so as not to convey equivalence of therapies.